Clinical Trial Update: A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa

View source ↗

Summary

This clinical trial, sponsored by AbbVie, is evaluating changes in sleep disturbances in adults with advanced Parkinson's disease treated with subcutaneous fosl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• foslevodopa/foscarbidopa (foslevodopa/foscarbidopa)

Snippet

Sponsor: AbbVie | Conditions: Advanced Parkinson's Disease | Status: RECRUITING